Recently, Gallia et al. [48] exhibited some data suggesting that inhibition of the AKT pathway eliminates the growth of GBM and GBM stem-like cells, implicating a role for AKT in BTSC survival and proliferation. The gene discussed is AKT1; the disease is glioblastoma.